News & Press Releases

FDA Chair Bethany Hills and ML Strategies Senior Director Aaron Josephson are featured in this article discussing two recently-announced actions by the Food & Drug Administration (FDA) to encourage industry adoption of two accelerated review and development pathways for new devices. The FDA’s announcement centered upon a final guidance on the breakthrough devices pathway and recommendations for a new Safer Technologies Program (STeP).

This feature article looks at a recent federal court decision striking down the Affordable Care Act (ACA). The piece notes that while the decision will not immediately effect the ACA's implementation, there could be significant consequences down the road if the decision is ultimately upheld. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in the piece.

This feature story looks at a new revised bill focused on the Food & Drug Administration’s (FDA) regulation of diagnostics. The piece notes that the bill, currently being reviewed by members of Congress, would provide a great number of updates including the ability for FDA to leverage a pre-certification process to validate test developers. ML Strategies Senior Director Aaron Josephson is among the industry sources providing commentary in the piece.

As health care costs continue to rise, this article looks at efforts being taken at the state and local levels targeting factors like housing, transportation, food and other nonmedical services as ways to overall improve the population's health while keeping medical costs down. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in this article

This feature article notes that the future of the Affordable Care Act (ACA) remains uncertain for now in spite of the fact that a Texas District Court recently found that it is unconstitutional. Veteran health care policy advisor and ML Strategies Vice President Rodney Whitlock is among the industry sources quoted.

ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in this article discussing the implications on prescription drug pricing as a result of Senator Chuck Grassley’s return to leading the Finance Committee.